Continuous subcutaneous insulin infusion for type 2 diabetes
- PMID: 24998010
- DOI: 10.1016/S0140-6736(14)61098-9
Continuous subcutaneous insulin infusion for type 2 diabetes
Comment on
-
Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.Lancet. 2014 Oct 4;384(9950):1265-72. doi: 10.1016/S0140-6736(14)61037-0. Epub 2014 Jul 2. Lancet. 2014. PMID: 24998009 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
